D-1089-2017 Class III Terminated
FDA drug recall D-1089-2017 was initiated by Akorn Inc on Jul 12, 2017 and is designated Class III. Reason for recall: Crystallization with subpotent out of specification assay results for chlorhexidine. The recall status is terminated (terminated Jun 19, 2018). Affected quantity: 40,978 unit dose cups.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 23, 2017
- Initiation Date
- Jul 12, 2017
- Termination Date
- Jun 19, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40,978 unit dose cups
Product description
Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse. Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97012
Reason for recall
Crystallization with subpotent out of specification assay results for chlorhexidine.
Distribution pattern
Nationwide in the USA
Code information
Lots: 0202623109, 0202623110, 0202623111, 0202630207, 0202630208, 0202630209, EXP 06-2018; 0202642227, 0202642228, 0202647413, 0202647414, 0202653433, 0202653434, EXP 07-2018.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1089-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026